OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+5.71%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$102M
AUM Growth
+$102M
(-26%)
Cap. Flow
-$32.6M
Cap. Flow
% of AUM
-32.05%
Top 10 Holdings %
Top 10 Hldgs %
98.25%
Holding
12
New
–
Increased
1
Reduced
2
Closed
1
Top Buys
| 1 |
ESSA Pharma
EPIX
|
$3.8M |
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$34.4M |
| 2 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
$1.11M |
| 3 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$858K |
Sector Composition
| 1 | Healthcare | 97.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $33.8M | 33.22% | 2,600,410 | – | – |
|
|
SNNA
2
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $14.2M | 14% | 758,610 | – | – |
|
|
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $13.5M | 13.26% | 1,000,000 | – | – |
|
|
JNCE
4
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $11.8M | 11.64% | 529,965 -49,685 | -9% | -$1.11M |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $7.16M | 7.04% | 551,477 | – | – |
|
6
FibroGen
FGEN
$47.8M
| $6.04M | 5.93% | 130,646 | – | – |
|
|
PVLA
7
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $5.31M | 5.22% | 778,230 -125,823 | -14% | -$858K |
|
|
8
ESSA Pharma
EPIX
$11.4M
| $4.12M | 4.05% | 21,696,969 +20,000,000 | +1,179% | +$3.8M |
|
|
DRNA
9
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.14M | 2.1% | 223,457 | – | – |
|
|
EGLT
10
DELISTED
Egalet Corporation
EGLT
| $1.82M | 1.79% | 2,889,926 | – | – |
|
11
Cidara Therapeutics
CDTX
$1.66B
| $1.78M | 1.75% | 444,965 | – | – |
|
|
JUNO
12
DELISTED
Juno Therapeutics, Inc.
JUNO
| – | – | -753,564 | Closed | -$34.4M |
|